On this page
Check the regulatory status
The FDA identifies retatrutide as an unapproved drug and warns about products sold as “research” compounds for human use. A tracking preset is not a prescription, approval, or recommendation to buy a product.
If you participate in a clinical trial
Follow the study team’s instructions and required reporting system. Ask whether a separate personal log is appropriate. An app does not replace trial monitoring, study records, or contact with the research team.
Keep unknowns visible
Do not invent an approved dose, formulation, or reliable medication curve. If a record is incomplete, retain that uncertainty rather than assigning a familiar medicine’s values to it.
Use sources, not product listings
The FDA resource below explains concerns about unapproved GLP-1 products. We do not provide purchasing links, preparation instructions, or a retatrutide dosing schedule.
Sources & further reading
Educational information, not medical advice. If something feels urgent or wrong, contact your clinician or emergency services.